Cover Image
市場調查報告書

中國的Megestrol市場分析:2010年∼2019年

Investigation Report on China Megestrol Market, 2010-2019

出版商 China Research and Intelligence 商品編碼 331523
出版日期 內容資訊 英文 30 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
中國的Megestrol市場分析:2010年∼2019年 Investigation Report on China Megestrol Market, 2010-2019
出版日期: 2015年05月28日 內容資訊: 英文 30 Pages
簡介

Megestrol,進入中國市場之後,顯示急速成長。年度銷售額,從2010年的2,995萬人民幣,到2014年達成3,722萬人民幣,以年複合成長率5.58%成長。

本報告提供中國的Megestrol市場相關調查分析、市場規模、市場佔有率、零售價格、主要製造商、市場預測等相關的系統性資訊。

第1章 Megestrol的相關概念

  • 適應
  • 全球市場銷售情形

第2章 中國的Megestrol的市場簡介

  • 專利狀況
  • 主要製造商
  • 市場規模

第3章 中國的Megestrol銷售情形分析

  • 銷售額
  • 銷售額數量

第4章 中國的Megestrol主要廠商的市場佔有率分析

  • 市場佔有率:各銷售額
  • 市場佔有率:各銷售額數量

第5章 中國的Megestrol的各劑型分析

  • 市場佔有率 (各劑型) :各銷售額
  • 市場佔有率 (各劑型) :各銷售額數量

第6章 中國的Megestrol的醫院用標準價格

  • Shanghai Sine Tianping Pharmaceutical Co., Ltd (商品名:Que Nuo)
  • Guccess (商品名:JIADI)
  • Gerui Pharmaceutical Company (商品名:Yi Li Zhi)
  • Zhejiang Wanlian Pharmaceutical Co., Ltd (商品名:Mi TuoSuo)
  • Deten Pharmaceutical (商品名:Ai Nuo Ke)

第7章 中國市場的Megestrol的主要製造商

  • Gerui Pharmaceutical Company
  • Guccess
  • Shanghai Sine Tianping Pharmaceutical Co., Ltd
  • Deten Pharmaceutical
  • Zhejiang Wanlian Pharmaceutical Co., Ltd

第8章 中國的Megestrol的市場預測

  • 市場規模的預測
  • 競爭情形的預測

圖表

目錄
Product Code: 1505185

Nowadays, breast cancer has the highest incidence among malignancy for women all over the world. According to the statistics released by World Health Organization (WHO), the number of breast cancer cases around the world reaches 1.2 million per year while a global death toll is about 0.5 million per year. In the past decade, the annual growth rate of the incidence of breast cancer hit 8%. By 2020, the incidence of cancer will increase by 50% and the number of new cases of cancer around the world will reach 15 million per year.

In recent years, the growth rate of the incidence of breast cancer in China ranks first in the world with one in ten women suffering from breast cancer. In 2015, the number of new cases of breast cancer in China has surpassed that of the US and become the largest in the world. In 2014, the number of newly confirmed cases of breast cancer was 0.225 million, increasing sharply by 50% compared with 2004. At the same time, nearly two thirds of newly confirmed cases can survive for more than 20 years with a long-term survival rate rising sharply by 20%. According to WTO, this astonishing progress benefits from the discovery and sale of new drugs with better efficacy and fewer adverse reactions.

About two thirds of breast cancer patients use hormone therapy. Common varieties of progestin are medroxyprogesterone and megestrol which act by blocking the source of human estrogen with an unsatisfactory efficacy rate of 30%-50%. Since their efficacy is not better than other drugs for breast cancer and their price is relatively high, their sales is not very big. But according to the latest domestic reports, progestin occupies nearly 2% of clinical medication for breast cancer with rising sales. After entering Chinese market, Megestrol develops very fast. Although its sales in 2011 underwent a small decline, it still enjoys an obvious growth trend in recent years. The annual sales of megestrol rose from CNY 29.95 million in 2010 to CNY 37.22 million in 2014 with a compound growth rate of 5.58%.

Readers can get at least the following information through this report:

  • market size of megestrol in China
  • major manufacturers of megestrol for Chinese market and their market share
  • retail price of megestrol in Chinese market
  • market outlook of megestrol in China

The author suggests the following groups of people purchase this report:

  • manufacturers of progestin
  • investors/ research institutions interested in Chinese medicine market
  • any interest in medicine market in China, please contact CRI for customized survey service

Table of Contents

1. Related Concepts of Megestrol

  • 1.1. Indication
  • 1.2. Sales Status in Global Market

2. Market Profile of Megestrol in China

  • 2.1. Patent Status
  • 2.2. Major Manufacturers
  • 2.3. Market Size

3. Survey on Sales Status of Megestrol in China, 2010-2014

  • 3.1. Sales Value
    • 3.1.1. Overall Sales Value
    • 3.1.2. Sales Value by Regions
  • 3.2. Sales Volume
    • 3.2.1. Overall Sales Volume
    • 3.2.2. Sales Volume by Regions

4. Survey on Market Share of Major Manufacturers of Megestrol in China, 2010-2014

  • 4.1. Market Share by Sales Value
  • 4.2. Market Share by Sales Volume

5. Survey on Dosage Forms of Megestrol in China, 2010-2014

  • 5.1. Share of Different Dosage Forms by Sales Value
  • 5.2. Share of Different Dosage Forms by Sales Volume

6. Reference Price of Megestrol in Chinese Hospitals in 2014

  • 6.1. Shanghai Sine Tianping Pharmaceutical Co., Ltd (Trade Name: Que Nuo)
  • 6.2. Guccess (Trade Name: JIADI)
  • 6.3. Gerui Pharmaceutical Company (Trade Name: Yi Li Zhi)
  • 6.4. Zhejiang Wanlian Pharmaceutical Co., Ltd (Trade Name: Mi TuoSuo)
  • 6.5. Deten Pharmaceutical (Trade Name: Ai Nuo Ke)

7. Major Manufacturers of Megestrol for Chinese Market, 2010-2014

  • 7.1. Gerui Pharmaceutical Company
  • 7.2. Guccess
  • 7.3. Shanghai Sine Tianping Pharmaceutical Co., Ltd
  • 7.4. Deten Pharmaceutical
  • 7.5. Zhejiang Wanlian Pharmaceutical Co., Ltd

8. Market Outlook of Megestrol in China, 2015-2019

  • 8.1. Forecast of Market Size
  • 8.2. Forecast of Competitive Landscape

Selected Charts

  • Chart Drug Registration Information of Megestrol in China
  • Chart Sales Status of Megestrol in Chinese Market, 2010-2014
  • Chart Sales Value of Megestrol in China, 2010-2014
  • Chart Sales Value of Megestrol by Regions in China, 2010-2014
  • Chart Sales Volume of Megestrol in China, 2010-2014 (unit: million)
  • Chart Sales Value and Market Share of TOP5 Manufacturers of Megestrol in Chinese Market, 2010-2014
  • Chart Sales Value and Market Share of Megestrol Made by Gerui, 2010-2014
  • Chart Sales Value and Market Share of Megestrol Made by Deten, 2010-2014
  • Chart Market Share of TOP5 Manufacturers of Megestrol by Sales Value in Chinese Market, 2010-2014
  • Chart Sales Volume and Market Share of Megestrol Made by Shanghai Sine Tianping, 2010-2014
  • Chart Sales Value and Market Share of Megestrol Tablets in China, 2010-2014
  • Chart Price of Megestrol Made by Shanghai Sine Tianping Pharmaceutical Co., Ltd in Some Cities in China, 2014
  • Chart Price of Megestrol Made by Guccess in Some Cities in China, 2014
  • Chart Price of Megestrol Made by Deten Pharmaceutical in Some Cities in China, 2014
Back to Top